As of 2025-10-17, the EV/EBITDA ratio of OPKO Health Inc (OPK) is -16.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPK's latest enterprise value is 1,267.48 mil USD. OPK's TTM EBITDA according to its financial statements is -76.84 mil USD. Dividing these 2 quantities gives us the above OPK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 16.5x | 14.6x |
| Forward P/E multiples | 14.4x - 15.7x | 15.2x |
| Fair Price | (1.21) - 1.71 | 0.06 |
| Upside | -180.8% - 13.7% | -95.7% |
| Date | EV/EBITDA |
| 2025-10-15 | -16.70 |
| 2025-10-14 | -16.70 |
| 2025-10-13 | -16.60 |
| 2025-10-10 | -16.60 |
| 2025-10-09 | -17.11 |
| 2025-10-08 | -17.01 |
| 2025-10-07 | -16.91 |
| 2025-10-06 | -17.32 |
| 2025-10-03 | -17.11 |
| 2025-10-02 | -16.91 |
| 2025-10-01 | -17.01 |
| 2025-09-30 | -17.01 |
| 2025-09-29 | -16.18 |
| 2025-09-26 | -15.98 |
| 2025-09-25 | -15.77 |
| 2025-09-24 | -16.29 |
| 2025-09-23 | -15.87 |
| 2025-09-22 | -15.87 |
| 2025-09-19 | -15.98 |
| 2025-09-18 | -16.60 |
| 2025-09-17 | -15.36 |
| 2025-09-16 | -15.36 |
| 2025-09-15 | -15.25 |
| 2025-09-12 | -15.46 |
| 2025-09-11 | -15.77 |
| 2025-09-10 | -15.56 |
| 2025-09-09 | -15.56 |
| 2025-09-08 | -15.67 |
| 2025-09-05 | -14.94 |
| 2025-09-04 | -15.25 |
| 2025-09-03 | -15.25 |
| 2025-09-02 | -15.05 |
| 2025-08-29 | -15.25 |
| 2025-08-28 | -15.67 |
| 2025-08-27 | -15.67 |
| 2025-08-26 | -15.36 |
| 2025-08-25 | -15.36 |
| 2025-08-22 | -15.56 |
| 2025-08-21 | -15.25 |
| 2025-08-20 | -15.36 |
| 2025-08-19 | -15.05 |
| 2025-08-18 | -15.46 |
| 2025-08-15 | -15.15 |
| 2025-08-14 | -14.94 |
| 2025-08-13 | -14.94 |
| 2025-08-12 | -14.63 |
| 2025-08-11 | -14.43 |
| 2025-08-08 | -13.91 |
| 2025-08-07 | -13.71 |
| 2025-08-06 | -14.12 |